Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

MNKD

MannKind (MNKD)

MannKind Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:MNKD
DateTimeSourceHeadlineSymbolCompany
06/03/202210:00AMGlobeNewswire Inc.Mannkind to Host Product Theater and Booth at the American Diabetes Association’s 82nd Scientific Sessions in New Orleans, June 3-7NASDAQ:MNKDMannKind Corporation
06/01/20226:15AMTipRanksAnalysts’ Top Healthcare Picks: ChemoCentryx (CCXI), MannKind (MNKD)NASDAQ:MNKDMannKind Corporation
05/25/20224:10PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MNKDMannKind Corporation
05/24/20226:00AMGlobeNewswire Inc.MannKind’s Technosphere® Inhalation Platform Utilized in FDA-Approved Tyvaso DPI™NASDAQ:MNKDMannKind Corporation
05/19/20226:00AMGlobeNewswire Inc.MannKind Corporation to Ring the Nasdaq Stock Market Opening BellNASDAQ:MNKDMannKind Corporation
05/17/20226:06AMGlobeNewswire Inc.MannKind Corporation Announces Agreement to Acquire V-Go® Insulin Delivery Device From Zealand PharmaNASDAQ:MNKDMannKind Corporation
05/09/20226:00AMGlobeNewswire Inc.MannKind Corporation Participating at Upcoming ConferencesNASDAQ:MNKDMannKind Corporation
05/08/202211:10AMTipRanksSVB Securities Thinks MannKind’s Stock is Going to RecoverNASDAQ:MNKDMannKind Corporation
05/06/20229:48PMTipRanksRBC Capital Keeps Their Hold Rating on MannKind (MNKD)NASDAQ:MNKDMannKind Corporation
05/05/20224:46PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MNKDMannKind Corporation
05/05/20224:16PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:MNKDMannKind Corporation
05/05/20224:00PMGlobeNewswire Inc.MannKind Corporation Reports 2022 First Quarter Financial ResultsNASDAQ:MNKDMannKind Corporation
04/28/20226:00AMGlobeNewswire Inc.MannKind Corporation to Hold 2022 First Quarter Financial Results Conference Call on May 5, 2022NASDAQ:MNKDMannKind Corporation
04/27/20226:05AMGlobeNewswire Inc.MannKind Presents Poster at 15th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2022) to Be Held April 27-30NASDAQ:MNKDMannKind Corporation
04/07/20229:47PMTipRanksMannKind (MNKD) Receives a Hold from RBC CapitalNASDAQ:MNKDMannKind Corporation
03/30/20229:11AMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:MNKDMannKind Corporation
03/29/202210:35PMTipRanksAnalysts Offer Insights on Healthcare Companies: Amarin (AMRN), Insmed (INSM) and MannKind (MNKD)NASDAQ:MNKDMannKind Corporation
03/28/20226:05AMGlobeNewswire Inc.MannKind Corporation to Participate in the Lytham Partners Spring 2022 Investor ConferenceNASDAQ:MNKDMannKind Corporation
03/22/20226:05AMGlobeNewswire Inc.MannKind Corporation to Participate in the Cantor Virtual Rare Orphan Disease SummitNASDAQ:MNKDMannKind Corporation
03/08/20226:05AMGlobeNewswire Inc.MannKind Corporation to Participate in Oppenheimer 32nd Annual Healthcare ConferenceNASDAQ:MNKDMannKind Corporation
03/01/20226:40PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MNKDMannKind Corporation
03/01/20226:14PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MNKDMannKind Corporation
03/01/20225:46PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MNKDMannKind Corporation
03/01/20225:32PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MNKDMannKind Corporation
03/01/20225:19PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MNKDMannKind Corporation
03/01/20225:19PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MNKDMannKind Corporation
02/24/20224:16PMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:MNKDMannKind Corporation
02/24/20224:09PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MNKDMannKind Corporation
02/24/20224:00PMGlobeNewswire Inc.MannKind Corporation Reports 2021 Fourth Quarter and Full Year Financial ResultsNASDAQ:MNKDMannKind Corporation
02/24/202211:54AMDow Jones NewsMannKind Shares Slump 20% After Delay in FDA Review of Tyvaso DPINASDAQ:MNKDMannKind Corporation
 Showing the most relevant articles for your search:NASDAQ:MNKD